Bromantane

Bromantane is a Soviet-era actoprotector drug developed in the late 1980s for military use under extreme heat and physical stress conditions. Unlike classical stimulants, it works by upregulating the dopamine synthesis enzyme (aromatic amino acid decarboxylase) rather than releasing or blocking reuptake of dopamine. This mechanism makes it non-addictive and less prone to tolerance. It also has unique immunostimulant properties. WADA banned it in 1996 after several positive tests. Russian clinical trials show it reduces fatigue, improves physical performance in heat, and reduces anxiety without sedation. It has a dedicated following in advanced nootropic communities for its clean energy profile.